We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.27B
AUM Growth
+$72.4M
Cap. Flow
+$10.4M
Cap. Flow %
0.82%
Top 10 Hldgs %
22.23%
Holding
250
New
28
Increased
87
Reduced
104
Closed
21

Top Buys

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$15.2M
2
TRTN
Triton International Limited
TRTN
+$13.5M
3
TTD icon
Trade Desk
TTD
+$10.6M
4
RAMP icon
LiveRamp
RAMP
+$10.2M
5
BOX icon
Box
BOX
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 32.47%
2 Healthcare 18.64%
3 Industrials 16.06%
4 Consumer Discretionary 8.64%
5 Financials 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPS icon
176
Digital Turbine
APPS
$1.74B
$741K 0.06%
414,124
+182,148
+79% +$300K
OKTA icon
177
Okta
OKTA
$25.8B
$735K 0.06%
+28,715
New +$803K
NEWR
178
DELISTED
New Relic, Inc.
NEWR
$731K 0.06%
12,657
+7,257
+134% +$395K
P
179
DELISTED
Pandora Media Inc
P
$698K 0.05%
144,800
+39,300
+37% +$235K
GOGO icon
180
Gogo Inc
GOGO
$493M
$697K 0.05%
61,828
+25,333
+69% +$270K
CTG
181
DELISTED
Computer Task Group, Inc.
CTG
$682K 0.05%
133,758
+19,730
+17% +$102K
INFN
182
DELISTED
Infinera Corporation Common Stock
INFN
$636K 0.05%
100,514
-159,321
-61% -$1.21M
NMRK icon
183
Newmark Group
NMRK
$2.63B
$620K 0.05%
+39,000
New +$597K
FENC icon
184
Fennec Pharmaceuticals
FENC
$402M
$592K 0.05%
59,044
+9,451
+19% +$94.3K
VIVE
185
DELISTED
VIVEVE MED INC
VIVE
$583K 0.05%
117
+15
+15% +$78.1K
HDSN
186
Hudson Technologies
HDSN
$235M
$476K 0.04%
78,390
+26,405
+51% +$161K
VYNT
187
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$471K 0.04%
1,696
+113
+7% +$43.1K
BABA icon
188
Alibaba
BABA
$308B
$437K 0.03%
2,532
-2,238
-47% -$401K
SONY icon
189
Sony
SONY
$138B
$409K 0.03%
45,455
-11,705
-20% -$101K
AVEO
190
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$382K 0.03%
+13,691
New +$425K
AAMI
191
Acadian Asset Management
AAMI
$3.19B
$373K 0.03%
22,295
-8,919
-29% -$142K
IVZ icon
192
Invesco
IVZ
$13.9B
$372K 0.03%
10,185
-4,328
-30% -$157K
FBRX icon
193
Forte Biosciences
FBRX
$1.57B
$370K 0.03%
96
+12
+14% +$47.9K
NVO
194
Novo Nordisk
NVO
$209B
$368K 0.03%
13,722
-6,870
-33% -$175K
ELUX
195
DELISTED
AKTIEB. ELECTROLUX B ADR SPNSD
ELUX
$361K 0.03%
5,589
-2,226
-28% -$144K
PHG icon
196
Philips
PHG
$26.1B
$346K 0.03%
12,062
-6,425
-35% -$194K
COO icon
197
Cooper Companies
COO
$14.5B
$344K 0.03%
6,308
PC
198
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
$332K 0.03%
22,559
-10,973
-33% -$161K
RIO icon
199
Rio Tinto
RIO
$164B
$329K 0.03%
6,212
-2,449
-28% -$120K
VSTM icon
200
Verastem
VSTM
$610M
$306K 0.02%
+8,299
New +$375K

Similar funds

Granahan Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Granahan Investment Management held 250 positions worth $1.27B, up 6% from $1.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Granahan Investment Management's Q4 2017 filing shows 28 new, 87 increased, 104 reduced and 21 closed positions. Its largest new stake was Triton International Limited: 351,589 shares worth $13.2M. The largest sale was LendingTree, an estimated $16.2M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q4 2017 buy was Triton International Limited: 351,589 shares worth $13.2M.
  • Granahan Investment Management added most to Evolent Health in Q4 2017, an estimated $15.2M increase.
  • Granahan Investment Management's biggest Q4 2017 reduction was LendingTree, cutting an estimated $16.2M.
  • Granahan Investment Management fully exited Veeva Systems in Q4 2017, selling an estimated $9.76M.
  • Granahan Investment Management's ten largest holdings make up 22% of its $1.27B portfolio in Q4 2017.
  • Granahan Investment Management opened 28 new positions and closed 21 in Q4 2017.
  • Granahan Investment Management's portfolio value rose 6% quarter-over-quarter to $1.27B.

Based on Granahan Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.